These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31799226)

  • 1. Variations in Umbilical Cord Hematopoietic and Mesenchymal Stem Cells With Bronchopulmonary Dysplasia.
    Chaudhury S; Saqibuddin J; Birkett R; Falcon-Girard K; Kraus M; Ernst LM; Grobman W; Mestan KK
    Front Pediatr; 2019; 7():475. PubMed ID: 31799226
    [No Abstract]   [Full Text] [Related]  

  • 2. Cord Blood Biomarkers of Placental Maternal Vascular Underperfusion Predict Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
    Mestan KK; Gotteiner N; Porta N; Grobman W; Su EJ; Ernst LM
    J Pediatr; 2017 Jun; 185():33-41. PubMed ID: 28162769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants.
    Chen X; Li H; Qiu X; Yang C; Walther FJ
    BMC Pediatr; 2019 Apr; 19(1):138. PubMed ID: 31039810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D and bronchopulmonary dysplasia in preterm infants.
    Joung KE; Burris HH; Van Marter LJ; McElrath TF; Michael Z; Tabatabai P; Litonjua AA; Weiss ST; Christou H
    J Perinatol; 2016 Oct; 36(10):878-82. PubMed ID: 27467562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
    Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J
    Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic Factors in Cord Blood of Preterm Infants Predicts Subsequently Developing Bronchopulmonary Dysplasia.
    Yang WC; Chen CY; Chou HC; Hsieh WS; Tsao PN
    Pediatr Neonatol; 2015 Dec; 56(6):382-5. PubMed ID: 25997993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumoprotein CC16 in the Umbilical Cord Blood of Preterm Neonates.
    Rallis D; Papathanasiou AE; Christou H
    Am J Perinatol; 2024 May; 41(S 01):e3367-e3373. PubMed ID: 38160675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood cytokines during the perinatal period in very preterm infants: relationship of inflammatory response and bronchopulmonary dysplasia.
    Paananen R; Husa AK; Vuolteenaho R; Herva R; Kaukola T; Hallman M
    J Pediatr; 2009 Jan; 154(1):39-43.e3. PubMed ID: 18760808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia.
    Borghesi A; Massa M; Campanelli R; Bollani L; Tzialla C; Figar TA; Ferrari G; Bonetti E; Chiesa G; de Silvestri A; Spinillo A; Rosti V; Stronati M
    Am J Respir Crit Care Med; 2009 Sep; 180(6):540-6. PubMed ID: 19574444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic administration of human umbilical cord-derived mesenchymal stem/stromal cells for bronchopulmonary dysplasia: preliminary outcomes in four Vietnamese infants.
    Nguyen LT; Trieu TTH; Bui HTH; Hoang VT; Nguyen ATT; Trinh NTH; Nguyen KT; Hoang DM
    J Transl Med; 2020 Oct; 18(1):398. PubMed ID: 33081796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
    Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
    [No Abstract]   [Full Text] [Related]  

  • 12. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6.
    Chaubey S; Thueson S; Ponnalagu D; Alam MA; Gheorghe CP; Aghai Z; Singh H; Bhandari V
    Stem Cell Res Ther; 2018 Jun; 9(1):173. PubMed ID: 29941022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired growth at birth and bronchopulmonary dysplasia classification: beyond small for gestational age.
    Nyp MF; Taylor JB; Norberg M; Truog WE
    Am J Perinatol; 2015 Jan; 32(1):75-82. PubMed ID: 24839148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
    Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
    JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features and prognosis of preterm infants with varying degrees of bronchopulmonary dysplasia].
    Li WL; Xu FL; Niu M; Liu MD; Dong HF
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Apr; 20(4):261-266. PubMed ID: 29658448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stromal cells and TGF-β1 in tracheal aspirate of premature infants: early predictors for bronchopulmonary dysplasia?
    Aly H; Mansi Y; Ez El Din Z; Gabr Metwally H; Sabry A
    J Perinat Med; 2019 May; 47(4):470-477. PubMed ID: 30789824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated intravenous doses of human umbilical cord-derived mesenchymal stromal cells for bronchopulmonary dysplasia: results of a phase 1 clinical trial with 2-year follow-up.
    Cerro Marín MJD; Ormazábal IG; Gimeno-Navarro A; Álvarez-Fuente M; López-Ortego P; Avila-Alvarez A; Arruza Gómez L; González-Menchen C; Labrandero de Lera C; Lozano Balseiro M; Moreno Gutiérrez L; Melen Frajilich G; Ramírez Orellana M; Saldaña García N; Pavón Delgado A; Vento Torres M;
    Cytotherapy; 2024 Jun; 26(6):632-640. PubMed ID: 38556960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different subsets of circulating angiogenic cells do not predict bronchopulmonary dysplasia or other diseases of prematurity in preterm infants.
    Borghesi A; Massa M; Campanelli R; Garofoli F; Longo S; Cabano R; Mazzucchelli I; Tzialla C; Gavilanes AW; Gazzolo D; Manzoni P; Bollani L; Spinillo A; Rosti V; Stronati M
    Int J Immunopathol Pharmacol; 2013; 26(3):809-16. PubMed ID: 24067483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of serum interleukin-33 in preterm infants with bronchopulmonary dysplasia].
    Chen JL; Zhang CL
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jul; 22(7):716-720. PubMed ID: 32669167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of increased cord blood soluble endoglin with the development of bronchopulmonary dysplasia in preterm infants with maternal preeclampsia.
    Kim DH; Shin SH; Kim EK; Kim HS
    Pregnancy Hypertens; 2018 Jul; 13():148-153. PubMed ID: 30177044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.